0001968582-23-000568.txt : 20231002 0001968582-23-000568.hdr.sgml : 20231002 20231002182107 ACCESSION NUMBER: 0001968582-23-000568 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 231301001 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Cheng Andrew CENTRAL INDEX KEY: 0001778307 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 170 HARBOR WAY, 3RD FLOOR STREET 2: C/O AKERO THERAPEUTICS, INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001778307 XXXXXXXX LIVE 0001744659 Akero Therapeutics, Inc. 001-38944 601 Gateway Blvd. Suite 350 South San Francisco CA 94080 650-487-6488 Andrew Cheng Officer Common J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

75000 3491250 55602175 10/02/2023 NASDAQ Common 10/02/2023 Stock Option Exercise Issuer N 75000 10/02/2023 Cash N Andrew Cheng

C/o Issuer 601 Gateway Blvd. Suite 350 South San Francisco CA 94080

Common 07/03/2023 25000 1122041 Andrew Cheng

C/o Issuer 601 Gateway Blvd. Suite 350 South San Francisco CA 94080

Common 08/01/2023 25000 1078867 Andrew Cheng

C/o Issuer 601 Gateway Blvd. Suite 350 South San Francisco CA 94080

Common 09/01/2023 25000 1244248 Options to be exercised within 3 months from the date of filing. 10/02/2023 01/10/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Andrew Cheng